Literature DB >> 32063813

Benzodiazepine Use and Cognition in the Elderly.

Amber R Toombs1, Joon Y Jung1, Nicole D White1.   

Abstract

Benzodiazepines are commonly prescribed to treat insomnia in the elderly. The use of benzodiazepines in this population has been associated with various risks, including the potential to cause cognitive decline. The purpose of this article is to discuss the relationship between the use of benzodiazepines and cognitive decline, the importance of patient education when prescribing benzodiazepines in this population, and lifestyle modifications that can be used to help treat insomnia in older adults.
© 2018 The Author(s).

Entities:  

Keywords:  benzodiazepine; cognition; geriatric; insomnia

Year:  2018        PMID: 32063813      PMCID: PMC6993098          DOI: 10.1177/1559827618767381

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  13 in total

1.  Relaxation and sleep compression for late-life insomnia: a placebo-controlled trial.

Authors:  K L Lichstein; B W Riedel; N M Wilson; K W Lester; R N Aguillard
Journal:  J Consult Clin Psychol       Date:  2001-04

2.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

Review 3.  Benzodiazepine use and cognitive decline in the elderly.

Authors:  Jenna D Picton; Adriane Brackett Marino; Kimberly Lovin Nealy
Journal:  Am J Health Syst Pharm       Date:  2018-01-01       Impact factor: 2.637

4.  Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the Three-city study.

Authors:  Thibault Mura; Cécile Proust-Lima; Tasnime Akbaraly; Hélène Amieva; Christophe Tzourio; Hugues Chevassus; Marie-Christine Picot; Hélène Jacqumin-Gadda; Claudine Berr
Journal:  Eur Neuropsychopharmacol       Date:  2012-06-15       Impact factor: 4.600

5.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.

Authors:  C M Morin; C Colecchi; J Stone; R Sood; D Brink
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

6.  Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013.

Authors:  Marcus A Bachhuber; Sean Hennessy; Chinazo O Cunningham; Joanna L Starrels
Journal:  Am J Public Health       Date:  2016-02-18       Impact factor: 9.308

7.  An actigraphic comparison of sleep restriction and sleep hygiene treatments for insomnia in older adults.

Authors:  L Friedman; K Benson; A Noda; V Zarcone; D A Wicks; K O'Connell; J O Brooks; D L Bliwise; J A Yesavage
Journal:  J Geriatr Psychiatry Neurol       Date:  2000       Impact factor: 2.680

8.  Benzodiazepine use in the United States.

Authors:  Mark Olfson; Marissa King; Michael Schoenbaum
Journal:  JAMA Psychiatry       Date:  2015-02       Impact factor: 21.596

Review 9.  Evidence-based recommendations for the assessment and management of sleep disorders in older persons.

Authors:  Harrison G Bloom; Imran Ahmed; Cathy A Alessi; Sonia Ancoli-Israel; Daniel J Buysse; Meir H Kryger; Barbara A Phillips; Michael J Thorpy; Michael V Vitiello; Phyllis C Zee
Journal:  J Am Geriatr Soc       Date:  2009-05       Impact factor: 5.562

10.  Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.

Authors:  Cara Tannenbaum; Philippe Martin; Robyn Tamblyn; Andrea Benedetti; Sara Ahmed
Journal:  JAMA Intern Med       Date:  2014-06       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.